Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older
Clinical trial NCT00760617 · COMPLETED
Trial details
- NCT number
- NCT00760617
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-06
- Primary completion
- 2009-05-15
- Enrollment
- 526
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.